Article

New CBER Guidance, Posted 11 January 2002

Author(s):

BioPharm International Editors

Guidance for Industry: General Principles of Software Validation; Final Guidance for Industry and FDA Staff

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Related Content
Drug manufacturing process. Conveyor with medical ampoules line at a modern pharmaceutical plant. Pharmacology production, medicine industry from laboratory 2 factory, pharmacy. Healthcare, pharma 3D | Image Credit: © Corona Borealis - © Corona Borealis - stock.adobe.com
September 12th 2025

PDA 2025: How Strategic CAPA Builds Anti-Fragile Manufacturing Compliance

Feliza Mirasol
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
September 12th 2025

The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game

G-CON
Hand touching Telecommunication network and wireless mobile internet technology with 5G LTE data connection of global business, fintech, blockchain. | Image Credit: © greenbutterfly - © greenbutterfly - stock.adobe.com
September 12th 2025

PDA 2025: Leveraging AI for GxP Compliance in Drug Production

Feliza Mirasol
Mastering Antibody-Drug Conjugates
September 12th 2025

Mastering Antibody-Drug Conjugates

BIOVECTRA
Binary code and lock shape on pixellated screen | Image Credit: © JohanSwanepoel - © JohanSwanepoel - stock.adobe.com
September 12th 2025

PDA 2025: Data Governance and AI's Impact on Drug Manufacturing

Feliza Mirasol
Site Logo
September 12th 2025

Ease the burden of managing metabolite identification

SCIEX
© 2025 MJH Life Sciences

All rights reserved.